annual total liabilities:
$48.87B-$2.90B(-5.59%)Summary
- As of today (May 26, 2025), TAK annual total liabilities is $48.87 billion, with the most recent change of -$2.90 billion (-5.59%) on March 1, 2025.
- During the last 3 years, TAK annual total liabilities has fallen by -$12.53 billion (-20.41%).
- TAK annual total liabilities is now -37.05% below its all-time high of $77.62 billion, reached on March 31, 2019.
Performance
TAK Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$48.87B-$86.44M(-0.18%)Summary
- As of today (May 26, 2025), TAK quarterly total liabilities is $48.87 billion, with the most recent change of -$86.44 million (-0.18%) on March 1, 2025.
- Over the past year, TAK quarterly total liabilities has dropped by -$2.90 billion (-5.59%).
- TAK quarterly total liabilities is now -39.22% below its all-time high of $80.41 billion, reached on June 30, 2019.
Performance
TAK quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
TAK Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.6% | -5.6% |
| 3 y3 years | -20.4% | -20.4% |
| 5 y5 years | -34.8% | -34.8% |
TAK Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.4% | at low | -20.4% | at low |
| 5 y | 5-year | -34.8% | at low | -34.8% | at low |
| alltime | all time | -37.0% | +1138.2% | -39.2% | +621.5% |
TAK Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | $48.87B(-5.6%) | $48.87B(-0.2%) |
| Dec 2024 | - | $48.95B(-8.6%) |
| Sep 2024 | - | $53.58B(+2.3%) |
| Jun 2024 | - | $52.37B(+1.2%) |
| Mar 2024 | $51.76B(-9.3%) | $51.76B(-2.4%) |
| Dec 2023 | - | $53.04B(+1.6%) |
| Sep 2023 | - | $52.22B(-3.9%) |
| Jun 2023 | - | $54.36B(-4.7%) |
| Mar 2023 | $57.06B(-7.1%) | $57.06B(+2.1%) |
| Dec 2022 | - | $55.89B(+2.5%) |
| Sep 2022 | - | $54.51B(-3.9%) |
| Jun 2022 | - | $56.72B(-7.6%) |
| Mar 2022 | $61.40B(-12.4%) | $61.40B(-4.1%) |
| Dec 2021 | - | $64.02B(-1.0%) |
| Sep 2021 | - | $64.64B(-3.7%) |
| Jun 2021 | - | $67.11B(-4.3%) |
| Mar 2021 | $70.12B(-6.4%) | $70.12B(-5.4%) |
| Dec 2020 | - | $74.14B(+1.1%) |
| Sep 2020 | - | $73.32B(-0.4%) |
| Jun 2020 | - | $73.64B(-1.7%) |
| Mar 2020 | $74.89B(-3.5%) | $74.89B(+0.0%) |
| Dec 2019 | - | $74.89B(+0.9%) |
| Sep 2019 | - | $74.20B(-7.7%) |
| Jun 2019 | - | $80.41B(+3.6%) |
| Mar 2019 | $77.62B(+294.9%) | $77.62B(+130.0%) |
| Dec 2018 | - | $33.75B(+82.5%) |
| Sep 2018 | - | $18.50B(-2.3%) |
| Jun 2018 | - | $18.94B(-3.7%) |
| Mar 2018 | $19.66B(-8.3%) | $19.66B(-2.6%) |
| Dec 2017 | - | $20.19B(+0.1%) |
| Sep 2017 | - | $20.18B(-2.1%) |
| Jun 2017 | - | $20.61B(-3.9%) |
| Mar 2017 | $21.45B(+33.0%) | $21.45B(+18.9%) |
| Dec 2016 | - | $18.04B(-5.1%) |
| Sep 2016 | - | $19.00B(+0.3%) |
| Jun 2016 | - | $18.95B(+17.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | $16.13B(-7.4%) | $16.13B(-4.2%) |
| Dec 2015 | - | $16.83B(-0.7%) |
| Sep 2015 | - | $16.94B(-0.5%) |
| Jun 2015 | - | $17.03B(-2.2%) |
| Mar 2015 | $17.41B(-11.7%) | $17.41B(-0.0%) |
| Dec 2014 | - | $17.41B(-6.6%) |
| Sep 2014 | - | $18.65B(-4.6%) |
| Jun 2014 | - | $19.56B(-0.8%) |
| Mar 2014 | $19.71B(+8.3%) | $19.71B(+4.9%) |
| Dec 2013 | - | $18.80B(-3.5%) |
| Sep 2013 | - | $19.48B(+15.8%) |
| Jun 2013 | - | $16.83B(-7.6%) |
| Mar 2013 | $18.21B(+4.2%) | $18.21B(-5.8%) |
| Dec 2012 | - | $19.32B(-0.7%) |
| Sep 2012 | - | $19.46B(+1.8%) |
| Jun 2012 | - | $19.12B(+9.4%) |
| Mar 2012 | $17.48B(+123.8%) | $17.48B(-6.1%) |
| Dec 2011 | - | $18.62B(-1.8%) |
| Sep 2011 | - | $18.95B(+156.1%) |
| Jun 2011 | - | $7.40B(-5.3%) |
| Mar 2011 | $7.81B(+10.9%) | $7.81B(+8.3%) |
| Dec 2010 | - | $7.21B(+1.5%) |
| Sep 2010 | - | $7.10B(+4.8%) |
| Jun 2010 | - | $6.77B(-3.8%) |
| Mar 2010 | $7.04B(-1.3%) | $7.04B(+1.3%) |
| Dec 2009 | - | $6.95B(-4.0%) |
| Sep 2009 | - | $7.24B(+1.5%) |
| Mar 2009 | $7.13B(+35.3%) | $7.13B(+1.8%) |
| Dec 2008 | - | $7.01B |
| Mar 2008 | $5.27B(+1.7%) | - |
| Mar 2007 | $5.18B(-12.0%) | - |
| Mar 2006 | $5.89B(+16.1%) | - |
| Mar 2005 | $5.08B(-4.6%) | - |
| Mar 2004 | $5.32B(+27.8%) | - |
| Mar 2003 | $4.17B(+1.6%) | - |
| Mar 2002 | $4.10B(+3.9%) | - |
| Mar 2001 | $3.95B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total liabilities?
- What is the all time high annual total liabilities for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual total liabilities year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total liabilities?
- What is the all time high quarterly total liabilities for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly total liabilities year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total liabilities?
The current annual total liabilities of TAK is $48.87B
What is the all time high annual total liabilities for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total liabilities is $77.62B
What is Takeda Pharmaceutical Company Limited annual total liabilities year-on-year change?
Over the past year, TAK annual total liabilities has changed by -$2.90B (-5.59%)
What is Takeda Pharmaceutical Company Limited quarterly total liabilities?
The current quarterly total liabilities of TAK is $48.87B
What is the all time high quarterly total liabilities for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total liabilities is $80.41B
What is Takeda Pharmaceutical Company Limited quarterly total liabilities year-on-year change?
Over the past year, TAK quarterly total liabilities has changed by -$2.90B (-5.59%)